Study treatment targeting the immune system for hidradenitis
Part of Infections, Skin clinical trials.
This trial tests an immune-focused treatment strategy for adults with moderate-to-severe hidradenitis suppurativa (HS), especially for cases where surgery is needed. If eligible, you may get a planned study treatment and be compared to a group without HS undergoing a related surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 or older
- If you have HS: your HS is moderate to severe (Hurley grade 2 or higher)
- Your doctor recommends surgery for HS (excision/removal of affected areas)
- You have not used immune-related medicines in the last 6 months (except antibiotics)
- You can understand and read French well enough to join study steps
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called HB0043 for people with moderate to severe hidradenitis suppurativa (a skin condition causing painful lumps). It aims to see if the drug is safe and helps reduce symptoms.
This trial tests a new medication, SAR445399, for people with moderate to severe hidradenitis suppurativa (HS) who haven't improved with oral antibiotics. It aims to see if the drug safely reduces skin bumps and abscesses.
This trial tests whether taking capsules containing healthy gut bacteria (fecal microbiota transplant) can help treat hidradenitis suppurativa. You may qualify if you have HS and haven't taken antibiotics in the last 30 days.
This study looks at the physical and biological (body-related) characteristics of hidradenitis suppurativa. It may help researchers understand the condition better and improve future care.
This study tests a new medicine called LAD191 for people with moderate to severe hidradenitis suppurativa (HS) who haven't been helped enough by antibiotics. Researchers want to see if LAD191 safely reduces painful bumps and tunnels.
This study tests a new drug called LAD328 for hidradenitis suppurativa (HS), a chronic skin condition with painful lumps and abscesses. The trial is looking for adults with moderate-to-severe HS who haven't responded well to antibiotics to see if this new treatment can help reduce symptoms.
Hear when a new Hidradenitis Suppurativa trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.